1. Home
  2. ABCB vs GRFS Comparison

ABCB vs GRFS Comparison

Compare ABCB & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ameris Bancorp

ABCB

Ameris Bancorp

HOLD

Current Price

$85.47

Market Cap

5.1B

Sector

Finance

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.64

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCB
GRFS
Founded
1971
1940
Country
United States
Spain
Employees
N/A
25247
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
5.4B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
ABCB
GRFS
Price
$85.47
$7.64
Analyst Decision
Buy
Hold
Analyst Count
7
2
Target Price
$87.14
$10.15
AVG Volume (30 Days)
326.3K
607.3K
Earning Date
04-23-2026
07-28-2022
Dividend Yield
0.95%
1.80%
EPS Growth
15.61
N/A
EPS
1.63
N/A
Revenue
N/A
N/A
Revenue This Year
$14.70
$4.49
Revenue Next Year
$5.97
$6.42
P/E Ratio
$52.23
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$59.54
$7.39
52 Week High
$87.99
$11.14

Technical Indicators

Market Signals
Indicator
ABCB
GRFS
Relative Strength Index (RSI) 55.61 41.27
Support Level $73.11 $7.44
Resistance Level $86.16 $8.24
Average True Range (ATR) 1.56 0.16
MACD -0.03 -0.03
Stochastic Oscillator 88.01 24.07

Price Performance

Historical Comparison
ABCB
GRFS

About ABCB Ameris Bancorp

Ameris Bancorp is a bank holding company that operates through Ameris Bank, its subsidiary. The company operates branches in Georgia, Alabama, Florida, and South Carolina. It offers traditional banking services such as business banking, personal banking, checking, savings, mobile banking, and others. The bank is organized into four segments: the Banking Division, the Retail Mortgage Division, the Warehouse Lending Division and the Premium Finance Division. The company generates majority of its revenue from the banking division. The company intends to acquire banks in its geographic region to increase its market share and expand beyond its current market.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: